← Back to signals
LLY
HOLDEli Lilly and Company
Health Care
1.50
PEGY ratio
Rank #301
Why This Matters
This stock appears fairly valued relative to its growth and dividend yield. Strong projected growth of 58.0% annually over 5 years. Pays a 0.6% dividend yield.
LLY is fairly valued at 38.5x earnings with 25.0% capped growth (actual 58.0%) + 0.6% yield (PEGY 1.50). The stock is priced close to what its growth and income profile would suggest.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 58.0%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
38.5x
P/E Ratio
Growth
58.0%
5yr EPS
Income
0.6%
Div Yield
PEGY Components
PEGY Score1.50
Denominator25.6%
EPS (TTM)$28.14
Market Data
Price$1,082.20
ExchangeNYSE
S&P 500
What Changed
PEGY Score
1.48→1.50(+0.02)
Rank
#304→#301(+3 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only